Artiva Biotherapeutics (ARTV) Shareholder's Equity (2023 - 2026)

Artiva Biotherapeutics (ARTV) Shareholder's Equity (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 7.14 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 595,226.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - 502.95 Mn
10 Artiva Biotherapeutics 241.85 Mn 241.85 Mn - 87.85 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 87.85 Mn
Dec 31, 2025 109.97 Mn
Sep 30, 2025 129.22 Mn
Jun 30, 2025 149.04 Mn
Mar 31, 2025 168.78 Mn
Dec 31, 2024 186.64 Mn
Sep 30, 2024 201.00 Mn
Jun 30, 2024 -191.10 Mn
Mar 31, 2024 -174.67 Mn
Dec 31, 2023 -162.02 Mn
Sep 30, 2023 -151.45 Mn
Jun 30, 2023 -164.26 Mn